Truehand Inc’s AbbVie ABBV Stock Holding History

Truehand Inc’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$3M	Sell	22,157 -2,800	-11%	-$331K	1.76%	19
2021 Q3	$2.69M	Hold	24,957	–	–	1.59%	21
2021 Q2	$2.81M	Hold	24,957	–	–	1.66%	22
2021 Q1	$2.7M	Hold	24,957	–	–	1.65%	22
2020 Q4	$2.67M	Hold	24,957	–	–	1.76%	17
2020 Q3	$2.19M	Sell	24,957 -121	-0.5%	-$11.4K	1.58%	21
2020 Q2	$2.46M	Sell	25,078 -802	-3%	-$70.6K	1.9%	13
2020 Q1	$1.97M	Hold	25,880	–	–	1.86%	17
2019 Q4	$2.29M	Sell	25,880 -200	-0.8%	-$16.6K	1.74%	22
2019 Q3	$1.98M	Hold	26,080	–	–	1.54%	27
2019 Q2	$1.9M	Hold	26,080	–	–	1.45%	28
2019 Q1	$2.1M	Hold	26,080	–	–	1.6%	22
2018 Q4	$2.4M	Buy	+26,080	New	+$2.29M	2.04%	14

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Truehand Inc's ABBV Position: Q4 2021 in Review

Truehand Inc reduced its AbbVie (ABBV) stake by 11% in Q4 2021, selling an estimated $331K and leaving 22,157 shares worth $3M. The position accounts for 1.76% of the portfolio, ranked #19.

Truehand Inc first reported a position in ABBV in Q4 2018 and has held it in 13 quarters since. 2,981 funds tracked by Wall St. Rank hold ABBV as of Q4 2021.

Truehand Inc held 22,157 shares of AbbVie worth $3M as of Q4 2021.
Truehand Inc sold 2,800 AbbVie shares in Q4 2021, an estimated $331K.
AbbVie made up 1.76% of Truehand Inc's portfolio in Q4 2021, its #19 holding.
Truehand Inc first reported a position in AbbVie in Q4 2018 and has held it in 13 quarters since.
2,981 funds tracked by Wall St. Rank held AbbVie as of Q4 2021.

Based on Truehand Inc's 13F filing for Q4 2021, filed 9 Feb 2022.